mRNA market in 2021 grew exponentially due to the success of COVID-19 vaccines by BioNTech, Johnson and Johnson and Moderna. As this technology shows promise, manufacturers are looking for modern approaches to scale production to meet overwhelming demand. This webinar will focus on current manufacturing processes for producing mRNA for vaccines.
Complete the form below to access the on-demand webinar:
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
22320 Foothill Blvd. Suite 330, Hayward CA 94541
